RECRUITINGINTERVENTIONAL
Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment
About This Trial
The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question it aims to answer are: * Which diagnostic modality is preferred by patients and the general population? * Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality? * Are geographical differences present in regard to the preference for a diagnostic modality? Participants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio-economic status. This approach will allow us to correct for confounding factors.
Who May Be Eligible (Plain English)
Who May Qualify:
1. Individuals \>18yo to 75yo (upper age limit of Barrett's surveillance)
2. Access to computer or smartphone
3. Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese)
Who Should NOT Join This Trial:
1. Individuals less than 18yo and more than 75yo
2. Incarcerated individuals
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. Individuals \>18yo to 75yo (upper age limit of Barrett's surveillance)
2. Access to computer or smartphone
3. Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese)
Exclusion Criteria:
1. Individuals less than 18yo and more than 75yo
2. Incarcerated individuals
Treatments Being Tested
OTHER
Survey
Discrete choice survey
Locations (1)
University Hospitals Leuven
Leuven, Belgium